Gyre Therapeutics | 7.96 +0.81 +11.33% | ||
| GYRE | |||
| 高 8.50 | 开 7.75 | 量 33.12万股 | 总市值 7.67亿 |
| 低 7.75 | 换 0.34% | 额 268.60万 | 市盈TTM 184.07 |
分时
5日
日K
周K
月K
季K
年K
Gyre Therapeutics(GYRE)
09-10 21:05
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001140361-25-034506 Act: 34 Size: 4 MB 网页链接
Gyre Therapeutics(GYRE)
08-27 04:15
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-032719 Size: 5 KB 网页链接
Gyre Therapeutics(GYRE)
08-27 04:05
$Gyre Therapeutics(GYRE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001140361-25-032710 Size: 11 KB 网页链接
Gyre Therapeutics(GYRE)
08-12 05:15
$Gyre Therapeutics(GYRE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-106644 Act: 34 Size: 15 MB 网页链接
Gyre Therapeutics(GYRE)
08-08 08:05
$Gyre Therapeutics(GYRE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-25-029693 Size: 5 KB 网页链接
Gyre Therapeutics(GYRE)
08-12 04:05
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 2.02, 5.02, 7.01, and 9.01 Accession Number: 0000950170-25-106525 Act: 34 Size: 681 KB 网页链接
Gyre Therapeutics(GYRE)
08-22 19:15
$Gyre Therapeutics(GYRE)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001140361-25-032295 Act: 34 Size: 185 KB 网页链接